ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,909.03
      -1.11%
      US Tech 100
      20,654.80
      -1.56%
      Dow Jones
      42,528.36
      -0.42%
      Brent Oil
      77.185
      0.16%
      Bitcoin
      96,706.69
      -0.20%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Denali Therapeutics Inc (DNLI) Quote

      Denali Therapeutics Inc

      Denali Therapeutics Inc (DNLI)

      NASDAQ
      21.18
      1.36
      (6.86%)
      Closed January 07 4:00PM
      Delayed by 15 minutes
      21.50
      0.32
      (1.51%)
      After Hours: 7:58PM
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      21.50
      Bid
      21.40
      Ask
      22.00
      Volume
      1,660,734
      18.69 Day's Range 21.61
      14.56 52 Week Range 33.33
      Market Cap
      3.094B
      Previous Close
      19.82
      Open
      18.75
      Last Trade
      7794
      @
      21.5
      (formt)
      Last Trade Time
      Financial Volume
      $ 34,999,320
      VWAP
      21.0746
      Average Volume (3m)
      852,530
      Shares Outstanding
      143,921,624
      Dividend Yield
      -
      PE Ratio
      -21.01
      Earnings Per Share (EPS)
      -1.01
      Revenue
      330.53M
      Net Profit
      -145.22M

      About Denali Therapeutics Inc

      Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates ... Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. Show more

      Sector
      Biological Pds,ex Diagnstics
      Industry
      Biological Pds,ex Diagnstics
      Website
      www.denalitherapeutics.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Denali Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker DNLI. The last closing price for Denali Therapeutics was $19.82. Over the last year, Denali Therapeutics shares have traded in a share price range of $ 14.56 to $ 33.33.

      Denali Therapeutics currently has 143,921,624 shares outstanding. The market capitalization of Denali Therapeutics is $2.85 billion. Denali Therapeutics has a price to earnings ratio (PE ratio) of -21.01.

      Ask ADVFN Intelligence (AI)

      Denali Therapeutics (DNLI) Options Flow Summary

      DNLI Options Flow

      Overall Flow

      Bearish

      Net Premium

      -1k

      Calls / Puts

      100.00%

      Buys / Sells

      0.00%

      OTM / ITM

      100.00%

      Sweeps Ratio

      0.00%

      DNLI Latest News

      More News

      Form 144 - Report of proposed sale of securities

      2 hours ago
      Edgar (US Regulatory)

      Form 144 - Report of proposed sale of securities

      2 hours ago
      Edgar (US Regulatory)

      Form 144 - Report of proposed sale of securities

      2 hours ago
      Edgar (US Regulatory)

      Form 144 - Report of proposed sale of securities

      2 hours ago
      Edgar (US Regulatory)

      Form 144 - Report of proposed sale of securities

      2 hours ago
      Edgar (US Regulatory)

      Form 144 - Report of proposed sale of securities

      2 hours ago
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      3 hours ago
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      3 hours ago
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      4 hours ago
      Edgar (US Regulatory)

      FeaturedEzFill Holdings, Inc. Successfully Closes Acquisition of Shell Fleet, Accelerating Nationwide Mobile Fueling Expansion

      14 hours ago
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      11.095.3405193532620.4121.5819.7386261420.37480337CS
      4-3.46-13.862179487224.9625.4819.7397619621.7240649CS
      12-5.42-20.133729569126.9233.3319.7385253024.79178107CS
      260.130.60832943378621.3733.3319.7390704325.18171404CS
      522.2411.630321910719.2633.3314.56103976921.8553303CS
      156-21.85-50.403690888143.3544.214.5682789324.93889218CS
      2604.2724.782356355217.2393.9412.3973719532.02674436CS

      DNLI - Frequently Asked Questions (FAQ)

      What is the current Denali Therapeutics share price?
      The current share price of Denali Therapeutics is $ 21.50
      How many Denali Therapeutics shares are in issue?
      Denali Therapeutics has 143,921,624 shares in issue
      What is the market cap of Denali Therapeutics?
      The market capitalisation of Denali Therapeutics is USD 2.85B
      What is the 1 year trading range for Denali Therapeutics share price?
      Denali Therapeutics has traded in the range of $ 14.56 to $ 33.33 during the past year
      What is the PE ratio of Denali Therapeutics?
      The price to earnings ratio of Denali Therapeutics is -21.01
      What is the cash to sales ratio of Denali Therapeutics?
      The cash to sales ratio of Denali Therapeutics is 9.23
      What is the reporting currency for Denali Therapeutics?
      Denali Therapeutics reports financial results in USD
      What is the latest annual turnover for Denali Therapeutics?
      The latest annual turnover of Denali Therapeutics is USD 330.53M
      What is the latest annual profit for Denali Therapeutics?
      The latest annual profit of Denali Therapeutics is USD -145.22M
      What is the registered address of Denali Therapeutics?
      The registered address for Denali Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
      What is the Denali Therapeutics website address?
      The website address for Denali Therapeutics is www.denalitherapeutics.com
      Which industry sector does Denali Therapeutics operate in?
      Denali Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      DATSDatChat Inc
      $ 8.82
      (350.00%)
      		204.88M
      HOTHHoth Therapeutics Inc
      $ 2.22
      (170.86%)
      		417.91M
      DRIODarioHealth Corporation
      $ 1.5479
      (81.68%)
      		2.5M
      SVMHSRIVARU Holding Ltd
      $ 0.0829
      (79.05%)
      		1.39B
      SPISPI Energy Company Ltd
      $ 0.6755
      (57.09%)
      		136.41M
      DHAIDIH Holdings US Inc
      $ 1.7899
      (-38.70%)
      		1.52M
      CISOCISO Global Inc
      $ 1.70
      (-37.04%)
      		692.1k
      SLRNACELYRIN Inc
      $ 2.21
      (-36.68%)
      		11.57M
      BOXLBoxlight Corporation
      $ 1.16
      (-30.95%)
      		6.54M
      AMSTAmesite Inc
      $ 2.80
      (-30.86%)
      		943.11k
      XTIAXTI Aerospace Inc
      $ 0.1141
      (29.66%)
      		2.64B
      SVMHSRIVARU Holding Ltd
      $ 0.0829
      (79.05%)
      		1.38B
      CEROCERo Therapeutics Holdings Inc
      $ 0.0515
      (21.75%)
      		900.12M
      RIMEAlgorhythm Holdings Inc
      $ 0.22647
      (56.40%)
      		667.47M
      HOTHHoth Therapeutics Inc
      $ 2.22
      (170.86%)
      		415.2M

      DNLI Discussion

      View Posts
      Monksdream Monksdream 2 months ago
      DNLI under $30
      👍️0
      Monksdream Monksdream 2 months ago
      DNLI under $30
      👍️0
      Monksdream Monksdream 4 months ago
      DNLI new 52/high
      👍️0
      conix conix 2 years ago
      DNLI on Seeking Alpha

      https://seekingalpha.com/article/4570210-denali-need-patient-data-to-justify-that-high-valuation
      👍️0
      seward seward 2 years ago
      Up big, why?
      👍️0
      seward seward 3 years ago
      Up 5 pts AH news or random bid ?
      👍️0
      seward seward 4 years ago
      Add 55.55

      Been holding for 100+, flipping small shares
      👍️0
      seward seward 4 years ago
      More flipping.

      Filled for one share at 57 this morning. If it hits 62 I can buy coffee.

      hans
      👍️0
      seward seward 4 years ago
      Good earnings, flipped some in low 60s
      👍️0
      seward seward 4 years ago
      Adding a little on pullbacks, still looking to hold till it breaks 100 and then sone.
      👍️0
      seward seward 4 years ago
      Best stock I’ve ever seen. Next stop 100 ?
      👍️0
      seward seward 4 years ago
      Up up up. I suppose I should sell it some day. Maybe over 100 ?
      👍️0
      seward seward 4 years ago
      14 may not be in the cards. I may wait for 100.

      hans
      👍️0
      seward seward 6 years ago
      Up nice today for no apparent reason.

      hans
      👍️0
      Glider549 Glider549 6 years ago
      Interesting .
      Stockconsultant daut kom sent me here.
      Any debt? Toxic debt?
      👍️0
      Golden Cross Golden Cross 6 years ago
      Back to $14 then do it again!
      👍️0
      Golden Cross Golden Cross 6 years ago
      Looking into if they have a stake in private company Blaze Bioscience and their scorpion venom..GLTA
      👍️0
      seward seward 6 years ago
      In at 14.30, already near 17. Lucky.
      👍️0
      seward seward 6 years ago
      "Announces Advancement and Expansion of Its LRRK2 Inhibitor Clinical Program for Parkinson’s Disease"

      I bought some today

      hans
      👍️0

      Your Recent History

      NASDAQ
      DNLI
      Denali Therapeutics
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads